Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses.
about
Human breast cancer tissues contain abundant phosphatidylcholine(36∶1) with high stearoyl-CoA desaturase-1 expressionTargeting metabolism in breast cancer: How far we can go?Synthetic lethal screens as a means to understand and treat MYC-driven cancersMeta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.Multiple changes induced by fibroblasts on breast cancer cells.Histamine therapeutic efficacy in metastatic melanoma: Role of histamine H4 receptor agonists and opportunity for combination with radiation.Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expressionThe Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.Tumor heterogeneity at protein level as an independent prognostic factor in endometrial cancer.MYC in breast tumor progressionMYC and Breast Cancer.MYC-xing it up with PIK3CA mutation and resistance to PI3K inhibitors: summit of two giants in breast cancersCharacterization of pancreatic lesions from MT-tgf alpha, Ela-myc and MT-tgf alpha/Ela-myc single and double transgenic miceIsoform-specific ras activation and oncogene dependence during MYC- and Wnt-induced mammary tumorigenesisCross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells.MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases.Myc proteins in brain tumor development and maintenance.Epithelial cell organization suppresses Myc function by attenuating Myc expressionMYC amplification in breast cancer: a chromogenic in situ hybridisation studyPhospholipids as cancer biomarkers: Mass spectrometry-based analysis.Avoiding false-positive signals with nuclease-vulnerable molecular beacons in single living cellsFunctional genomics identifies therapeutic targets for MYC-driven cancer.Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes.mRNA stability and cancer: an emerging link?Oral administration of a gemini vitamin D analog, a synthetic triterpenoid and the combination prevents mammary tumorigenesis driven by ErbB2 overexpression.Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831.Detection of HER-2/neu, c-myc amplification and p53 inactivation by FISH in Egyptian patients with breast cancer.Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea.The ROCK signaling and breast cancer metastasis.c-myc in Kaposi's sarcoma: analyses by fluorescent in situ hybridization and immunohistochemistry.A c-Myc/miR-17-5p feedback loop regulates metastasis and invasion of hepatocellular carcinoma.Combined use of nuclear phosphoprotein c-Myc and cellular phosphoprotein p53 for hepatocellular carcinoma detection in high-risk chronic hepatitis C patients.Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress.MYC-Driven Pathways in Breast Cancer Subtypes.Decorin transfection induces proteomic and phenotypic modulation in breast cancer cells 8701-BC.Association of C-myc and p53 Gene Expression and Polymorphisms with Hepatitis C (HCV) Chronic Infection, Cirrhosis and Hepatocellular Carcinoma (HCC) Stages in Egyptc-Myc suppresses p21WAF1/CIP1 expression during estrogen signaling and antiestrogen resistance in human breast cancer cells.BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potentialDistribution of the c-MYC gene product in colorectal neoplasia.
P2860
Q21090768-AF981500-F99E-4E00-8832-54429241AE70Q26767022-9E087960-BC66-4351-88D2-5108329575A7Q27006010-DA344EDB-B431-47FE-9FAA-015354297E9FQ33416006-9BE30C77-49B1-4104-9D36-0B37DE5B7036Q33517777-F62AE302-3D4A-4A05-982A-8C89FB38C22AQ33688711-D155EF35-2B0E-46E8-B2A0-AEA196DF1E91Q33978087-CBD67C38-4BCF-4B4A-A752-352DE7782310Q34273280-AA4F3F64-3C1E-45BF-924F-31E35C6CC012Q34439115-7E42A5AF-F2C8-49B7-8F4D-313E9373D0D5Q34478381-07BC0A8C-8DED-45FD-8DEA-48C39C91209AQ34524915-43668636-B6B4-4750-A740-BE2A024BA193Q34972381-A6AEFC37-1EF2-4DF8-A164-53A9D750FE0AQ34991267-E0B57A5B-ACF4-46C5-BB1D-DFE9D678F444Q35016285-83E7B9D5-7609-4655-BF23-ABDF8FB83154Q35131418-CC61B8AF-BFD8-44A3-8F2B-B1F981C9E7EAQ35235623-7534C7F3-2797-4307-AA51-2B20BAE6D116Q35753606-EED7FB50-3DF0-4D67-9651-449224154577Q35920494-89030FD1-7ECA-42D6-A0C0-2960CF093908Q35944851-F625C80C-B18B-4A6E-94B9-9A536A66376AQ35984487-49089282-B7E7-475B-80F0-8594F350932AQ36045221-5AC4AF49-502F-419D-A013-6970EE284948Q36059533-A0835EF8-8633-4E47-A179-59F7D4B42DAAQ36066213-B03AD1DB-F0CE-443E-B940-3538DA7D98E8Q36393112-BDF14159-D6BA-4DB0-B7ED-1FAFF908154EQ36960486-0A6D5521-9A80-4AD3-8AD5-A61A919E8AF2Q37156523-3E6CBA83-C993-4CA5-A137-5D93EC708DB3Q37246798-E462AABF-C327-4E25-94BB-E635C4DA96F2Q37277274-E8EDB906-C4D1-41F8-B758-5021549BC15CQ37382070-99A3ADB9-785C-4C6C-95AA-78216069D144Q37770084-F1CB77DF-A468-418E-B1AE-25CEAB4FA837Q38401727-C73445B3-8BE5-4F30-9B6A-22E573E9F081Q38821369-98963BB2-028B-4FA1-B623-96B7F15D4987Q38883226-0A6758D8-FF77-4BB3-9E3D-01BCF362334CQ38936778-D461FE2F-AEBE-471E-996E-5F98EE14C647Q39428256-A8BCD850-8988-41A4-A215-B339FD288F24Q40010017-FCB40226-F7F4-475C-8C5F-4C070BD520E4Q40078961-CB7E83AC-6C1F-46F9-89C0-ACBBEEE8F403Q40448475-95064BD2-5E29-4419-A5F1-0BB656D5B87EQ40907759-0A841661-10BA-4CDE-9ADC-583B6ACC668DQ41850038-A6290F4E-D047-489A-B606-5E49B53546E0
P2860
Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Correlation of amplification a ...... immunohistochemical analyses.
@ast
Correlation of amplification a ...... immunohistochemical analyses.
@en
type
label
Correlation of amplification a ...... immunohistochemical analyses.
@ast
Correlation of amplification a ...... immunohistochemical analyses.
@en
prefLabel
Correlation of amplification a ...... immunohistochemical analyses.
@ast
Correlation of amplification a ...... immunohistochemical analyses.
@en
P2093
P2860
P356
P1476
Correlation of amplification a ...... immunohistochemical analyses.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601703
P407
P577
2004-04-01T00:00:00Z
P5875
P6179
1040904483